Page 370 - Biến Chứng Bệnh Đái Tháo Đường

16. American Diabetes Association: Treatment of hypertension

in adult with diabetes. Supp 1. S80-S83. 2003.

17. Bakris GL. Williams M. Toto R. Douglas J. Preserving

Renal tunction in adult with hypertension and diabetes: a

consensus approach Am. J. Kid. Dis. 36. 646-661.2000.

# •
•

18. Brewer BM Cooper ME Keane WF: Effects of Losartan on

renal and cardiovascular out - come inpatient with type 2

diabetes Nephropathy. N. Eng. J. Med. 345.861-869.2001.

19. Lewis ES. Clark WR Berl T. Rono — protective effect of

The Angiotensin receptor antagonist Irbesartan impatient

with type 2 diabetes Nephropathy. N. Eng. J. Med. 851.

960.345.2001.

20. UK prospective diabetes study group: Efficacy of actnolol

and captopril in reducing the risk of macro - vascular

complication in type 2 diabetes (UKPDS 39) BMJ 317-

713-720.1998.

21. UK prospective diabetes study group: Tight blood

pressure control and risk of Macro - vascular

complications in type 2 713 - 720. 1998.

22. Mogensen CE. Keane Bernett PH: Prevention of diabetes

ranal disease with special reference to Microalbumin.

Laucet 346 1080 - 1084. 1995.

23. Stout LC. Knumars whotorn EB. Focal uresangiolysis and

the pathogenesis of the Kimmelstiel — Wilson nodule.

Hum - pathol. 24.77.89.1993.

24. Kunzr. Borkjp Frische L. Association between the

Angiotensin - converting enzyme - insertion/deletion

polymorphism and diabetic nephropathy: A methodology

appraisal and systematic review. J. Amsoe Nephrol 9.

1653. 1663. 1998.

25. Elia. Friedman Neuphropathy: A Major diabetic

complication. Endocrinology Vol. 1. 879 - 902 - 2001.

374